Applications are reviewed on a rolling basis. We accept up to 10,000 contributors. If approved, you'll get a link to activate Claude Max on your account for the subscription period. Apply below.
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
。服务器推荐对此有专业解读
This Tweet is currently unavailable. It might be loading or has been removed.
Why the FT?See why over a million readers pay to read the Financial Times.
What is expected of directors?